Your browser doesn't support javascript.
loading
Follow-up blood cultures in Staphylococcus aureus bacteremia: a probability-based optimization.
Van Goethem, Sam; Boogaerts, Hélène; Cuykx, Matthias; van den Bremen, Pol; Wouters, Kristien; Goossens, Herman; Jansens, Hilde; Ten Kate, Gerrit Luit.
  • Van Goethem S; Laboratory of Medical Microbiology, Antwerp University Hospital, Drie Eikenstraat 655, 2650, Edegem, Belgium. sam.vangoethem@icloud.com.
  • Boogaerts H; Laboratory of Medical Microbiology, Antwerp University Hospital, Drie Eikenstraat 655, 2650, Edegem, Belgium.
  • Cuykx M; Laboratory of Medical Microbiology, Antwerp University Hospital, Drie Eikenstraat 655, 2650, Edegem, Belgium.
  • van den Bremen P; University of Antwerp, Edegem, Belgium.
  • Wouters K; Clinical Trial Center (CTC), CRC Antwerp, Antwerp University Hospital, University of Antwerp, Edegem, Belgium.
  • Goossens H; Laboratory of Medical Microbiology, Antwerp University Hospital, Drie Eikenstraat 655, 2650, Edegem, Belgium.
  • Jansens H; Laboratory of Medical Microbiology, Antwerp University Hospital, Drie Eikenstraat 655, 2650, Edegem, Belgium.
  • Ten Kate GL; Department of General Internal Medicine, Infectious Diseases and Tropical Medicine, Antwerp University Hospital, Drie Eikenstraat 655, 2650, Edegem, Belgium. Gerritluit.tenkate@uza.be.
Eur J Clin Microbiol Infect Dis ; 41(10): 1263-1268, 2022 Oct.
Article en En | MEDLINE | ID: mdl-36066759
ABSTRACT
Staphylococcus aureus bacteremia (SAB) is a relevant finding which prompts a thorough diagnostic work-up. Follow-up blood cultures (BC) are essential in this work-up. We investigate the probability of detecting an ongoing bacteremia after initiation of active therapy according to the number of BC taken at key time points. A retrospective analysis of all patients with SAB in a 6-year period was performed. Total number of BCs taken and the positivity was registered for each day after start of therapy. A positivity-rate was corrected using a logistic mixed effects model. Observed detection frequencies were applied to calculate detection probabilities using binomial distributions. Three hundred and seventeen cases were withheld for analysis. A BC bottle positivity rate of 66.7% was found 1 day after initiation of active therapy, which decreased to 48.5% on day 4. When using 1 set of FU-BC, 73.4% of persisting SABs are detected. To maintain a probability of detection of ≥ 90%, 2 BC sets should be taken on day 2 and day 4 after start of therapy. In 10 of 109 patients with positive FU-BC, skip phenomena were registered, with a significant higher proportion in patients with < 4 BC bottles taken (14%) than when ≥ 4 BC bottles were taken (4.1%). We recommend taking 2 BC sets on days 2 and 4 after start of therapy in order to detect ≥ 90% of persisting SABs, limiting skip phenomena and blood volume required. We strongly advice against taking a single BC set as follow-up for SAB.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones Estafilocócicas / Bacteriemia Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones Estafilocócicas / Bacteriemia Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article